Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Acute oxcarbazepine-induced hepatotoxicity in a patient susceptible to developing drug-induced liver injury.

Planjar-Prvan M, Bielen A, Sruk A, Marusić M, Bielen I.

Coll Antropol. 2013 Mar;37(1):281-4.

PMID:
23697284
2.

[Hepatic tolerance of atypical antipsychotic drugs].

Dumortier G, Cabaret W, Stamatiadis L, Saba G, Benadhira R, Rocamora JF, Aubriot-Delmas B, Glikman J, Januel D.

Encephale. 2002 Nov-Dec;28(6 Pt 1):542-51. Review. French.

PMID:
12506267
3.

[Oxcarbazepine].

Arroyo S.

Neurologia. 2001 Oct;16(8):370-5. Spanish.

PMID:
11738014
4.

Oxcarbazepine monotherapy for partial-onset seizures: a multicenter, double-blind, clinical trial.

Beydoun A, Sachdeo RC, Rosenfeld WE, Krauss GL, Sessler N, Mesenbrink P, Kramer L, D'Souza J.

Neurology. 2000 Jun 27;54(12):2245-51.

PMID:
10881247
5.

What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs?

Schmidt D, Elger CE.

Epilepsy Behav. 2004 Oct;5(5):627-35. Review.

PMID:
15380112
6.

[Clinic-epidemiological significance of drug hepatotoxicity in liver disease consultation].

Jmelnitzky AC, Guidi M, Bologna A, Viola M, Soccini C, Barbero R, Belloni P, Apraiz M.

Acta Gastroenterol Latinoam. 2000;30(2):77-84. Spanish.

PMID:
10925723
7.

Cutaneous reactions induced by oxcarbazepine in Southern Han Chinese: incidence, features, risk factors and relation to HLA-B alleles.

He N, Min FL, Shi YW, Guo J, Liu XR, Li BM, Zhou JH, Ou YM, Liao JX, Liao WP.

Seizure. 2012 Oct;21(8):614-8. doi: 10.1016/j.seizure.2012.06.014. Epub 2012 Jul 20.

8.

Oxcarbazepine-induced hyponatremia and the regulation of serum sodium after replacing carbamazepine with oxcarbazepine in children.

Holtmann M, Krause M, Opp J, Tokarzewski M, Korn-Merker E, Boenigk HE.

Neuropediatrics. 2002 Dec;33(6):298-300.

PMID:
12571784
9.

Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.

Juruena MF, Ottoni GL, Machado-Vieira R, Carneiro RM, Weingarthner N, Marquardt AR, Fleig SS, Broilo L, Busnello EA.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Feb 1;33(1):94-9. doi: 10.1016/j.pnpbp.2008.10.012. Epub 2008 Oct 31.

PMID:
19007842
10.

A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients.

McKee PJ, Blacklaw J, Forrest G, Gillham RA, Walker SM, Connelly D, Brodie MJ.

Br J Clin Pharmacol. 1994 Jan;37(1):27-32.

12.

Oxcarbazepine in bipolar disorder: a critical review of the literature.

Mazza M, Di Nicola M, Martinotti G, Taranto C, Pozzi G, Conte G, Janiri L, Bria P, Mazza S.

Expert Opin Pharmacother. 2007 Apr;8(5):649-56. Review.

PMID:
17376019
13.

Lamotrigine-associated reversible severe hepatitis: a case report.

Su-Yin AN, Tai WW, Olson KR.

J Med Toxicol. 2008 Dec;4(4):258-60.

14.

Risk factors of oxcarbazepine-induced hyponatremia in patients with epilepsy.

Lin CH, Lu CH, Wang FJ, Tsai MH, Chang WN, Tsai NW, Lai SL, Tseng YL, Chuang YC.

Clin Neuropharmacol. 2010 Nov-Dec;33(6):293-6. doi: 10.1097/WNF.0b013e3181f80bd4.

PMID:
20881597
15.

[Oxcarbazepine in the treatment of epilepsy].

Freidel M, Krause E, Kuhn K, Peper R, Vogel H.

Fortschr Neurol Psychiatr. 2007 Feb;75(2):100-6. Epub 2007 Jan 2. German.

PMID:
17200915
16.

Worsening of seizures by oxcarbazepine in juvenile idiopathic generalized epilepsies.

Gelisse P, Genton P, Kuate C, Pesenti A, Baldy-Moulinier M, Crespel A.

Epilepsia. 2004 Oct;45(10):1282-6.

17.

Cross-reactivity of skin rashes with current antiepileptic drugs in Chinese population.

Wang XQ, Lang SY, Shi XB, Tian HJ, Wang RF, Yang F.

Seizure. 2010 Nov;19(9):562-6. doi: 10.1016/j.seizure.2010.09.003.

18.

Acute antimanic efficacy and safety of oxcarbazepine in an open trial with an on-off-on design.

Hummel B, Walden J, Stampfer R, Dittmann S, Amann B, Sterr A, Schaefer M, Frye MA, Grunze H.

Bipolar Disord. 2002 Dec;4(6):412-7.

PMID:
12519102
19.

Lack of enzyme induction with oxcarbazepine (600 mg daily) in healthy subjects.

Larkin JG, McKee PJ, Forrest G, Beastall GH, Park BK, Lowrie JI, Lloyd P, Brodie MJ.

Br J Clin Pharmacol. 1991 Jan;31(1):65-71.

20.

Supplemental Content

Support Center